Concepedia

Joseph G. Naglich

JG

Statistics

Publications

19

Citations

1.6K

H-Index

17

Active since

1984

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

The University of Texas Southwestern Medical Center

Bristol-Myers Squibb (Sweden)

Nerviano Medical Sciences

Joseph G. Naglich is an author at Bristol-Myers Squibb (United States) specializing in life sciences, molecular oncology, and molecular biology.

Publications per year

1984–2018

19

Publications

19

Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor

Joseph G. Naglich, James E. Metherall, David W. Russell et al. · Cell · 1992 · 549 citations

Life Sciences, Immunology, Molecular Biology +13

Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Jean M. Whaley, Joseph G. Naglich, Lawrence M. Gelbert et al. · PubMed · 1994 · 237 citations

Medicine, Genetics, Molecular Genetics +12

Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

Catherine Blankenship, Joseph G. Naglich, Jean M. Whaley et al. · Oncogene · 1999 · 142 citations

Life Sciences, Genetics, Molecular Biology +17

Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.

Joseph G. Naglich, Maria Jure‐Kunkel, Elora Gupta et al. · PubMed · 2001 · 114 citations

Medicine, Oncology, Pharmacology +12

The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity

Benjamin A. Seigal, William H. Connors, Andrew W. Fraley et al. · Journal of Medicinal Chemistry · 2015 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 19